Rectal colonization with vancomycin-resistant enterococci among high-risk patients in an Israeli hospital

Journal of Hospital Infection

Volumn 43, Issue 3, 1999, Pages 231-238

  Dan, M ^a   Poch, F ^a   Leibson, L ^a   Smetana, S ^a   Priel, I ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Intensive care unit; Rectal colonization; Renal dialysis; Vancomycin resistant enterococci

Indexed keywords

AMPICILLIN; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; QUINOLONE DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; FEMALE; HEMODIALYSIS; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; ISRAEL; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RECTUM; RISK FACTOR;

EID: 0032700907     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.1998.0641     Document Type: Article

References (19)

1. MMWR. 42:1993;597-599.
2. Noble W. C., Virani Z., Cree R. Cotransfer of vancomycin and other resistance genes form Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiology Letters. 93:1992;195-198.
3. Leclercq R., Courvalin P. Resistance to glycopeptides in enterococcci. Clin Infect Dis. 24:1997;545-546.
4. Shay D. K., Maloney S. A., Montecalvo M. Epidemiology and mortality risk of vancomycin-resistant-enterococcal bloodstream infections. J Infect Dis. 172:1995;993-1000.
5. 6th ed. Approved standards. M2 A6. 1997.
6. 4th ed. Approved standards, M7-A4. 1997.
7. Currie B. P., Grass S., Levi M. H. A hospital based rectal swab culture survey to detect vancomycin-resistant enterococci: Utility and Application. Int J Infect Dis. 1:1996;87-91.
8. Bonten M. J. M., Hayden M. K., Nathan C. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci. Lancet. 348:1996;1615-1619.
9. Handwerger S., Roucher B., Altarec D. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 16:1993;750-755.
10. Gordts B., Van Landuyt H., Ieven M., Vandamme P., Goossens H. Vancomycin-resistant enterococci colonizing the intestinal tract of hospitalized patients. J Clin Microbiol. 33:1995;2842-2846.
11. Troidle L., Kliger A. S., Gorban-Brennan N., Fikrig M., Golden M., Finkelstein F. O. Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci. Kidney Int. 50:1996;1368-1372.
12. Sanyal D., Williams A. J., Johnson A. P., George R. C. The emergence of vancomycin-resistance in renal dialysis. J Hosp Infection. 24:1993;167-173.
13. John J. F. Enterococcal infections. Infect Dis Alert. 12:1996;38-39.
14. Low C. L., Eisele G., Cerda J. et al. Low prevalence of vancomycin-resistant Enterococcus in dialysis outpatients with a history of vancomycin use (letter). Perit Dial Int. 16:1996;651-652.
15. Humar, A. Dedier, I. Campbell, J. et al., Clinical and microbiologic analysis of a vancomycin-resistant Enterococcus (VRE) outbreak in dialysis population. Presented at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1996 (#J3).
16. Montecalvo M. A., Horowitz H., Gedris C. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant bacteremia in an adult oncology unit. Antimicrob Agents Chemother. 38:1994;1363.
17. Ena J., Dick R. W., Jones R. N., Wenzel R. P. The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. JAMA. 269:1993;598-602.
18. Kirst H. A., Thompson D. G., Nicas T. J. Historical yearly usage of vancomycin. Antimicrob Agents Chemother. 42:1998;1303-1304.
19. Jarvis W. R. Epidemiology, appropriateness, and cost of vancomycin use. Clin Infect Dis. 26:1998;1200-1203.